A new report from a relatively small, single-institution study has provided additional information about the utility of [18F]fluciclovine (Axumin) PET/CT scans in the detection of recurrent prostate cancer after definitive first-line treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Axumin, fluciclovine, PET/CT, recurrence, scan | 2 Comments »
We had previously reported on a presentation by Calais et al. earlier this year. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: Axumin, fluciclovine, fluorine-18, gallium-68, imaging, PET/CT, PSMA, scan | 9 Comments »
According to a presentation given yesterday at the ASCO meeting here in Chicago, PET/CT scanning with 68Ga-PSMA-11 is more accurate than 18F-fluciclovine PET/CT at detecting recurrent prostate cancer in men with early biochemical recurrence following radical prostatectomy. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: fluciclovine, fluorine-18, gallium-68, PET, PET/CT, scan | 11 Comments »
A new article in the journal Cancer Imaging has provided us with an interesting set of “real world” data on the accuracy of gallium-68 PSMA PET/CT scans in the management of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: gallium-68, outc omes, PET/CT, PSMA, real world, scan | 14 Comments »
A group of Italian researchers have apparently shown that a copper-64 dichloride-based radiotracing agent (64CuCl2) is better than currently-used 18FCl radiotracers in the detection of biochemically recurrent prostate cancer with PET/CT scans … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: copper-64, imaging, PET/CT, radiotracer, scan | 3 Comments »
Because the success or failure of salvage radiation (SRT) hinges upon whether micrometastases are already systemic at the time of treatment, evidence that the cancer is still local improves the odds that SRT will be successful. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: mpMRI, PET/CT, PSMA, radition, salvage, therapy | 1 Comment »
A new paper in the Journal of Nuclear Medicine has reported the first use of [11C]sarcosine in combination with PET/CT scanning as a technique for imaging prostate cancer in man. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: carbon-11, imaging, PET/CT, sarcosine, scan | Leave a comment »
The gold standard for the clinical relevance of any new test in the management of a specific disease is … Do the results of the test change the way a physician would previously have managed patients? … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gallium-68, Management, PET/CT, PSMA, recurrence, scan | 3 Comments »
There seem to be clinical trials of new PET radiotracers for the detection of prostate cancer all the time. In addition to the FDA-approved [11C]choline, Na18F, FDG, and fluciclovine PET scans, most of the new PET scans target the PSMA protein on prostate cancer cells. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: bombesin, PET/CT, radiotracer, RGD, scan | 4 Comments »
The question of how much better the varied, new forms of imaging will be in the evaluation of patients with higher-risk prostate cancer both before and after their treatment is a currently “hot topic” in the world of prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: choline-C11, gallium-68, imaging, PET/CT, scan, test | 1 Comment »
The salvage treatment of men found to have positive lymph nodes after prior (surgical) treatment and the identification of such positive lymph nodes using techniques such as [11C]choline PET/CT scans is still not well established, but it does offer opportunity for some men. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: choline-11, node-positive, PET/CT, salvage, Treatment | 4 Comments »
A diagnostic or prognostic technique is valuable only insofar as it is able to change treatment decisions. A small Australian study claims that gallium-68-PSMA ([68Ga]PSMA) PET/CT scans could do this in about half the cases examined. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: gallium-68, PET/CT, PSMA, scan | Leave a comment »
PET/CT scans using the radioactive fluorinated inhibitor of prostate-specific membrane antigen (PSMA) known as 18F-DCFBC (or just DCFBC) are better at detecting metastases … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: 18F-DCFBC, Diagnosis, PET/CT, scan, utility, value | 11 Comments »
The advent of imaging tests like the [11C]choline PET/CT scan and others have made it possible to identify, relatively early, the presence of one or more foci of recurrent prostate cancer after first-line therapy, and often these recurrent foci can be found in patients’ pelvic lymph nodes. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: choline, lymph node, PET/CT, positive, recurrent, salvage, Treatment | 10 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 